• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease. Response to: Toth PP, Davidson MH: simvastatin and ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin. Pharmacother. (2005) 6(1):131-139.

作者信息

Ahmed Mohamed H, Saad Rasheed A, Osman Meissa M

出版信息

Expert Opin Drug Saf. 2006 Jul;5(4):487-8. doi: 10.1517/14740338.5.4.487.

DOI:10.1517/14740338.5.4.487
PMID:16774486
Abstract
摘要

相似文献

1
Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease. Response to: Toth PP, Davidson MH: simvastatin and ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin. Pharmacother. (2005) 6(1):131-139.依折麦布：治疗非酒精性脂肪性肝病相关血脂异常的有效且安全的疗法。回应：托特PP，戴维森MH：辛伐他汀和依折麦布：联合治疗血脂异常。专家观点。药物治疗学（2005年）6(1):131 - 139。
Expert Opin Drug Saf. 2006 Jul;5(4):487-8. doi: 10.1517/14740338.5.4.487.
2
[Efficacy and safety of ezetimibe/simvastatin combination therapy in patients with type 2 diabetes and nonalcoholic fatty liver disease].依折麦布/辛伐他汀联合治疗2型糖尿病合并非酒精性脂肪性肝病患者的疗效与安全性
Orv Hetil. 2009 May 24;150(21):989-93. doi: 10.1556/OH.2009.28624.
3
Ezetimibe combines with simvastatin to tackle cholesterol. New drugs attack "bad" cholesterol in the liver and intestine.依泽替米贝与辛伐他汀联合使用以降低胆固醇。新型药物可在肝脏和肠道中对抗“坏”胆固醇。
Heart Advis. 2007 Jul;10(7):7.
4
Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.依折麦布与辛伐他汀联合用于治疗高胆固醇血症。
Expert Opin Pharmacother. 2015 Jun;16(8):1255-62. doi: 10.1517/14656566.2015.1041504. Epub 2015 Apr 28.
5
Cholesterol drug controversy continues.胆固醇药物争议仍在继续。
JAMA. 2008 May 21;299(19):2266. doi: 10.1001/jama.299.19.2266.
6
The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia.辛伐他汀-依折麦布联合治疗对单纯高胆固醇血症患者脂肪组织激素和全身炎症的影响。
Cardiovasc Ther. 2014 Apr;32(2):40-6. doi: 10.1111/1755-5922.12057.
7
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study.依折麦布与辛伐他汀联合用药（益适纯）对比阿托伐他汀治疗高胆固醇血症患者的剂量比较研究：益适纯对比阿托伐他汀（VYVA）研究
Am Heart J. 2006 May;151(5):e1. doi: 10.1016/j.ahj.2005.10.009.
8
Amid lingering questions, FDA reprieves LDL cholesterol-lowering medication.
JAMA. 2009 Feb 25;301(8):813-5. doi: 10.1001/jama.2009.196.
9
Drug treats two sources of cholesterol.药物治疗胆固醇的两个来源。
Nurse Pract. 2005 Mar;30(3):70. doi: 10.1097/00006205-200503000-00023.
10
Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.辛伐他汀和依折麦布治疗高胆固醇血症的疗效。
J Am Coll Cardiol. 2003 Jul 16;42(2):398-9; author reply 399. doi: 10.1016/s0735-1097(03)00638-7.

引用本文的文献

1
Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.非酒精性脂肪性肝病的管理：一项基于证据的临床实践综述
World J Gastroenterol. 2014 Sep 14;20(34):12182-201. doi: 10.3748/wjg.v20.i34.12182.
2
Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy.癌症幸存者的护理：激素治疗后的代谢综合征。
Am J Med. 2010 Jan;123(1):87.e1-6. doi: 10.1016/j.amjmed.2009.06.022.